Notizie AIOM – anno XV
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
November 20, 2017 - The FDA has approved dasatinib for the treatment of pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. The approval is based on results in 97 pediatric patients with CP-CML enrolled across 2 studies with ...Leggi tutto
FDA Approval Sought for Frontline Daratumumab in Myeloma
November 21, 2017 - A supplemental biologics license application (sBLA) has been submitted to the FDA for daratumumab for use in combination with bortezomib, melphalan and prednisone (VMP) for the treatment of patients with newly diagnosed multiple myeloma who are ineligible ...Leggi tutto